Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

Regulation of Notch1/NICD and Hes1 Expressions by GSK-3α/β

  • Jin, Yun Hye (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Kim, Hangun (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Oh, Minsoo (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Ki, Hyunkyung (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Kim, Kwonseop (College of Pharmacy and Research Institute of Drug Development, Chonnam National University)
  • Received : 2008.04.15
  • Accepted : 2008.10.13
  • Published : 2009.01.31
⟨ Previous Next ⟩

Abstract

Notch signaling is controlled at multiple levels. In particular, stabilized Notch receptor activation directly affects the transcriptional activations of Notch target genes. Although some progress has been made in terms of defining the regulatory mechanism that alters Notch stability, it has not been determined whether Notch1/NICD stability is regulated by $GSK-3{\alpha}$. Here, we show that Notch1/NICD levels are significantly regulated by $GSK-3{\beta}$ and by $GSK-3{\alpha}$. Treatment with LiCl (a specific GSK-3 inhibitor) or the overexpression of the kinase-inactive forms of $GSK-3{\alpha}/{\beta}$ significantly increased Notch1/NICD levels. Endogenous NICD levels were also increased by either $GSK-3{\alpha}/{\beta}$- or $GSK-3{\alpha}$-specific siRNA. Furthermore, it was found that $GSK-3{\alpha}$ binds to Notch1. Deletion analysis showed that at least three Thr residues in Notch1 (Thr-1851, 2123, and 2125) are critical for its response to LiCl, which increased not only the transcriptional activity of endogenous NICD but also Hes1 mRNA levels. Taken together, our results indicate that $GSK-3{\alpha}$ is a negative regulator of Notch1/NICD.

Keywords

Acknowledgement

Supported by : Korean Science and Engineering Foundation

References

  1. Asuni, A.A., Hooper, C., Reynolds, C.H., Lovestone, S., Anderton, B.H., and Killick, R. (2006). GSK-3$\alpha$ exhibits$\beta$-catenin and tau directed kinase activities that are modulated by Wnt. Eur. J. Neurosci. 24, 3387-3392 https://doi.org/10.1111/j.1460-9568.2006.05243.x
  2. Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, A., Roux, P., Black, R.A., and Israel, A. (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207-216 https://doi.org/10.1016/S1097-2765(00)80417-7
  3. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hemmings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 https://doi.org/10.1038/378785a0
  4. Doble, B.W., Patel, S., Wood, G.A., Kockeritz, L.K., and Woodgett, J.R. (2007). Functional redundancy of GSK-3$\alpha$ and GSK-3$\beta$ in Wnt/$\beta$-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12, 957-971 https://doi.org/10.1016/j.devcel.2007.04.001
  5. Espinosa, L., Ingles-Esteve, J., Aguilera, C., and Bigas, A. (2003). Phosphorylation by glycogen synthase kinase-3 beta downregulates Notch activity, a link for Notch and Wnt pathways. J. Biol. Chem. 278, 32227-32235 https://doi.org/10.1074/jbc.M304001200
  6. Foltz, D.R., Santiago, M.C., Berechid, B.E., and Nye, J.S. (2002). Glycogen synthase kinase-3$\beta$ modulates notch signaling and stability. Curr. Biol. 12, 1006-1011 https://doi.org/10.1016/S0960-9822(02)00888-6
  7. Goto, H., Kawano, K., Kobayashi, I., Sakai, H., and Yanagisawa, S. (2002). Expression of cyclin D1 and GSK-3$\beta$ and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol. 38, 549-556 https://doi.org/10.1016/S1368-8375(01)00121-X
  8. Grimes, C.A., and Jope, R.S. (2001). The multifaceted roles of glycogen synthase kinase 3$\beta$ in cellular signaling. Prog. Neurobiol. 65, 391-426 https://doi.org/10.1016/S0301-0082(01)00011-9
  9. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., and Woodgett, J.R. (2000). Requirement for glycogen synthase kinase-3$\beta$ in cell survival and NF-$\kappa$B activation. Nature 406, 86-90 https://doi.org/10.1038/35017574
  10. Hughes, K., Nikolakaki, E., Plyte, S.E., Totty, N.F., and Woodgett, J.R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808
  11. Iso, T., Kedes, L., and Hamamori, Y. (2003). HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell Physiol. 194, 237-255 https://doi.org/10.1002/jcp.10208
  12. Kim, H., Ki, H., Park, H.S., and Kim, K. (2005). Presenilin-1 $D_{257}$and $D_{3}8_{5}$A mutants fail to cleave Notch in their endoproteolyzed forms, but only presenilin-1 TEX>$D_{3}8_{5}$A mutant can restore its $\gamma$-secretase activity with the compensatory overexpression of normal C-terminal fragment. J. Biol. Chem. 280, 22462-22472 https://doi.org/10.1074/jbc.M502769200
  13. Koivisto, L., Jiang, G., Hakkinen, L., Chan, B., and Larjava, H. (2006). HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3$\alpha$. Exp. Cell Res. 312, 2791-2805 https://doi.org/10.1016/j.yexcr.2006.05.009
  14. Kopan, R. (2002). Notch: a membrane-bound transcription factor. J. Cell Sci. 115, 1095-1097
  15. Lau, K.F., Miller, C.C., Anderton, B.H., and Shaw, P.C. (1999). Expression analysis of glycogen synthase kinase-3 in human tissues. J. Pept. Res. 54, 85-91 https://doi.org/10.1034/j.1399-3011.1999.00083.x
  16. Lee, H.C., Tsai, J.N., Liao, P.Y., Tsai, W.Y., Lin, K.Y., Chuang, C.C., Sun, C.K., Chang, W.C., and Tsai, H.J. (2007). Glycogen synthase kinase 3$\alpha$ and 3$\beta$ have distinct functions during cardiogenesis of zebrafish embryo. BMC Dev. Biol. 7, 93 https://doi.org/10.1186/1471-213X-7-93
  17. Liao, X., Thrasher, J.B., Holzbeierlein, J., Stanley, S., and Li, B. (2004). Glycogen synthase kinase-3$\beta$ activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology 145, 2941-2949 https://doi.org/10.1210/en.2003-1519
  18. Logeat, F., Bessia, C., Brou, C., LeBail, O., Jarriault, S., Seidah, N.G., and Israel, A. (1998). The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95, 8108-8112 https://doi.org/10.1073/pnas.95.14.8108
  19. Phiel, C.J., Wilson, C.A., Lee, V.M., and Klein, P.S. (2003). GSK- 3$\alpha$ regulates production of Alzheimer's disease amyloid-$\beta$ peptides. Nature 423, 435-439 https://doi.org/10.1038/nature01640
  20. Shaw, P.C., Davies, A.F., Lau, K.F., Garcia-Barcelo, M., Waye, M.M., Lovestone, S., Miller, C.C., and Anderton, B.H. (1998). Isolation and chromosomal mapping of human glycogen synthase kinase-3$\alpha$ and -3$\beta$ encoding genes. Genome 41, 720-727 https://doi.org/10.1139/gen-41-5-720
  21. Wang, Q.M., Fiol, C.J., DePaoli-Roach, A.A., and Roach, P.J. (1994). Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269, 14566-14574
  22. Woodgett, J.R. (1990). Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438
  23. Yao, H.B., Shaw, P.C., Wong, C.C., and Wan, D.C. (2002). Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J. Chem. Neuroanat. 23, 291-297 https://doi.org/10.1016/S0891-0618(02)00014-5

Cited by

  1. The Insulin-Like Growth Factor (IGF) Receptor Type 1 (IGF1R) as an Essential Component of the Signalling Network Regulating Neurogenesis vol.40, pp.3, 2009, https://doi.org/10.1007/s12035-009-8081-0
  2. GSK-3 is a master regulator of neural progenitor homeostasis vol.12, pp.11, 2009, https://doi.org/10.1038/nn.2408
  3. GSK3β is a negative regulator of the transcriptional coactivator MAML1 vol.37, pp.20, 2009, https://doi.org/10.1093/nar/gkp724
  4. Regulation of Notch1 signaling by delta-like ligand 1 intracellular domain through physical interaction vol.32, pp.2, 2009, https://doi.org/10.1007/s10059-011-1046-y
  5. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblasti vol.52, pp.7, 2011, https://doi.org/10.3109/10428194.2011.564696
  6. Functions of GSK-3 Signaling in Development of the Nervous System vol.4, pp.None, 2009, https://doi.org/10.3389/fnmol.2011.00044
  7. Myocardial Injection With GSK-3β-Overexpressing Bone Marrow-Derived Mesenchymal Stem Cells Attenuates Cardiac Dysfunction After Myocardial Infarction vol.108, pp.4, 2009, https://doi.org/10.1161/circresaha.110.229658
  8. Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines vol.137, pp.5, 2009, https://doi.org/10.1007/s00432-010-0934-4
  9. Role of STRAP in regulating GSK3β function and Notch3 stabilization vol.10, pp.10, 2009, https://doi.org/10.4161/cc.10.10.15630
  10. Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival vol.106, pp.5, 2011, https://doi.org/10.1007/s00395-011-0189-5
  11. Notch 1 signaling pathway effect on implantation competency vol.96, pp.5, 2009, https://doi.org/10.1016/j.fertnstert.2011.08.032
  12. From Dynamic Expression Patterns to Boundary Formation in the Presomitic Mesoderm vol.8, pp.6, 2009, https://doi.org/10.1371/journal.pcbi.1002586
  13. The structure of Wntch signalling and the resolution of transition states in development vol.23, pp.4, 2009, https://doi.org/10.1016/j.semcdb.2012.01.012
  14. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling vol.31, pp.43, 2012, https://doi.org/10.1038/onc.2011.589
  15. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response vol.27, pp.3, 2009, https://doi.org/10.1038/leu.2012.285
  16. GSK-3 as potential target for therapeutic intervention in cancer vol.5, pp.10, 2009, https://doi.org/10.18632/oncotarget.2037
  17. A balance of positive and negative regulators determines the pace of the segmentation clock vol.4, pp.None, 2009, https://doi.org/10.7554/elife.05842
  18. Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis vol.34, pp.27, 2009, https://doi.org/10.1038/onc.2014.279
  19. Phosphorylation-dependent regulation of Notch1 signaling: the fulcrum of Notch1 signaling vol.48, pp.8, 2009, https://doi.org/10.5483/bmbrep.2015.48.8.107
  20. Turn It Down a Notch vol.4, pp.None, 2016, https://doi.org/10.3389/fcell.2016.00151
  21. The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets vol.8, pp.32, 2009, https://doi.org/10.18632/oncotarget.17809
  22. Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson’s Disease: a Crosstalk with Wnt and Notch Signaling vol.55, pp.8, 2009, https://doi.org/10.1007/s12035-017-0860-4
  23. The function of Notch1 intracellular domain in the differentiation of gastric cancer vol.15, pp.5, 2009, https://doi.org/10.3892/ol.2018.8118
  24. Moving Breast Cancer Therapy up a Notch vol.8, pp.None, 2009, https://doi.org/10.3389/fonc.2018.00518
  25. PI5P4Kγ functions in DTX1-mediated Notch signaling vol.115, pp.9, 2009, https://doi.org/10.1073/pnas.1712142115
  26. FBXW7: a critical tumor suppressor of human cancers vol.17, pp.1, 2009, https://doi.org/10.1186/s12943-018-0857-2
  27. CDK 1 and CDK 2 regulate NICD 1 turnover and the periodicity of the segmentation clock vol.20, pp.7, 2009, https://doi.org/10.15252/embr.201846436
  28. Clinical Chemistry Route for Investigation of Alzheimer’s Disease: A Label-Free Electrochemiluminescent Biosensor for Glycogen Synthase Kinase-3 Beta vol.10, pp.8, 2009, https://doi.org/10.1021/acschemneuro.9b00278
  29. GSK3 regulates hair cell fate in the developing mammalian cochlea vol.453, pp.2, 2009, https://doi.org/10.1016/j.ydbio.2019.06.003
  30. Neural Differentiation Dynamics Controlled by Multiple Feedback Loops in a Comprehensive Molecular Interaction Network vol.8, pp.2, 2020, https://doi.org/10.3390/pr8020166
  31. The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers vol.1867, pp.9, 2020, https://doi.org/10.1016/j.bbamcr.2020.118738
  32. Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs vol.12, pp.5, 2009, https://doi.org/10.1038/s41419-021-03776-8
  33. A proteogenomic portrait of lung squamous cell carcinoma vol.184, pp.16, 2009, https://doi.org/10.1016/j.cell.2021.07.016
  34. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives vol.13, pp.20, 2009, https://doi.org/10.3390/cancers13205106